科学家制定针对记忆T细胞的治疗方法,以提供长效哮喘缓解。 Scientists develop treatments targeting memory T cells to provide long-lasting asthma relief.

La Jolla免疫学研究所的科学家开发了两种治疗性“鸡尾酒”,可为哮喘病人提供长期的救济。 Scientists at La Jolla Institute for Immunology have developed two therapeutic "cocktails" that could offer long-lasting relief for asthma patients. 这些治疗针对使专门的记忆T细胞保持活性、可引发哮喘发作的分子。 These treatments target molecules that keep specialized memory T cells active, which can trigger asthma attacks. 鸡尾酒在老鼠模型的试验中抑制了ICOSL、OX40L和CD30L分子,有可能帮助各种形式的过敏哮喘以及其他炎症和自发性免疫疾病。 Tested on a mouse model, the cocktails inhibit ICOSL, OX40L, and CD30L molecules, potentially helping various forms of allergic asthma and other inflammatory and autoimmune diseases.